Gabriele Bertotti

Prof. Dr. Gabriele Bertotti

Physiotherapy, Francisco de Vitoria University, Pozuelo de Alarcón, Spain
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2025 in Nutrition Reviews
Verified
Journal Article
Closed access
ARAlberto Roldán Ruiz
Alberto Roldán Ruiz
Gabriele BertottiGabriele Bertotti
Gabriele Bertotti
MLMiguel López-Moreno
Miguel López-Moreno
Context: Migraine is a disabling neurological disorder. Diet may be a factor to consider because measures of diet quality have been linked to both frequency and severity of attacks. Objectives: To investigate the effects of dietary interventions on the clinical symptoms of migraine, quality of life, and body composition of patients with migraine. Data Sources: The MEDLINE, Embase, and Web of Sciences databases were searched since database inception to February 13, 2024. We included articles on randomized clinical trials that assessed the effect dietary interventions on clinical symptoms of migraines and the quality of life and body composition of individuals with migraine. Data Extraction: Data from the included articles were independently extracted by 2 researchers; another independent reviewer further verified the extractions. The Cochrane risk-of-bias tool was used to evaluate the risk of bias of selected studies, and the Physiotherapy Evidence Database scale was used to assess the methodological quality. Results: Eight articles were included in this review. Of these, 3 reported on studies that assessed the ketogenic diet (KD), 2 reported on the Dietary Approaches to Stop Hypertension (DASH), and 3 reported on studies of other dietary strategies. Strong evidence exists regarding the effectiveness of the KD and DASH in reducing the frequency of migraine attacks, whereas their efficacy in improving patients’ quality of life was supported only by limited evidence. There also is strong evidence regarding the effectiveness of DASH in reducing migraine’s severity and patients’ body weight. Insufficient evidence was found regarding the effectiveness of the other dietary interventions on all variables. Conclusions: The DASH and KD may help reduce migraine frequency and severity. However, more high-quality studies are needed to confirm their effectiveness. Systematic Review Registration: PROSPERO No. CRD42024516161.

21 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Gabriele BertottiGabriele Bertotti
Gabriele Bertotti
VFVicente Fernández-Ruiz
Vicente Fernández-Ruiz
ARAlberto Roldán Ruiz
Alberto Roldán Ruiz
MLMiguel López-Moreno
Miguel López-Moreno
Migraine headache (MH) and cluster headache (CH) are debilitating primary headache disorders that impose a significant global burden. While they share certain clinical features, such as unilateral pain and autonomic dysfunction, their underlying pathophysiological mechanisms remain distinct. Advances in the understanding of neurophysiological features, such as neuroimaging and biomarker research, have provided critical insights into both their overlapping and divergent characteristics. Neurophysiological research has revealed differences in nociceptive processing, cortical excitability, and sensory integration, underscoring the complexity of these conditions. Neuroimaging studies reveal common activation patterns within pain-processing networks, including the trigeminal system and hypothalamus, while highlighting key differences, such as hypothalamic hyperactivity in CH and cortical alterations in MH. Additionally, biomarker research has identified shared elements, including elevated calcitonin gene-related peptide (CGRP), yet distinct variations in its regulation and genetic predispositions. Genome-wide association studies have further elucidated the genetic architecture of these disorders, uncovering susceptibility loci that reinforces their unique yet occasionally intersecting genetic foundations. These multifield advancements not only enhance the understanding of MH and CH pathophysiology but also pave the way for improved diagnostic precision, personalized therapeutic strategies, and future research.

17 April 2023 in Journal of Human Kinetics
Verified
Journal Article
Open access
LBLuis A. Berlanga
Luis A. Berlanga
Alvaro SamanesAlvaro Samanes
Alvaro Samanes
JMJulio Martin-Lopez
Julio Martin-Lopez
RCRuben Martinez de la Cruz
Ruben Martinez de la Cruz
MGMarta Garcés-Rimón
Marta Garcés-Rimón
Gabriele BertottiGabriele Bertotti
Gabriele Bertotti
Beetroot juice (BJ) is commonly used as an ergogenic aid in endurance and team sports, however, the effect of this supplement on climbing performance is barely studied. The purpose of the current study was to investigate the effect of acute BJ ingestion on neuromuscular and biochemical variables in amateur male sport climbers. Ten physically active sport climbers (28.8 ± 3.7 years) underwent a battery of neuromuscular tests consisting of the half crimp test, the pull-up to failure test, the isometric handgrip strength test, the countermovement jump (CMJ) and the squat jump (SJ). Participants performed the neuromuscular test battery twice in a cross-over design separated by 10 days, 150 min after having consumed either 70-mL of BJ (6.4 mmol NO3-) or a 70-mL placebo (0.0034 mmol NO3-). In addition, nitrate (NO3-) and nitrite (NO2-) saliva concentrations were analysed, and a side effect questionnaire related to ingestion was administrated. No differences were reported in particular neuromuscular variables measured such as the CMJ (p = 0.960; ES = 0.03), the SJ (p = 0.581; ES = −0.25), isometric handgrip strength (dominant/non dominant) (p = 0.459–0.447; ES = 0.34–0.35), the pull-up failure test (p = 0.272; ES = 0.51) or the maximal isometric half crimp test (p = 0.521–0.824; ES = 0.10–0.28). Salivary NO3- and NO2- increased significantly post BJ supplementation compared to the placebo (p < 0.001), while no side effects associated to ingestion were reported (p = 0.330–1.000) between conditions (BJ/placebo ingestion). Acute dietary nitrate supplementation (70-mL) did not produce any statistically significant improvement in neuromuscular performance or side effects in amateur sport climbers.

6 February 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Gabriele BertottiGabriele Bertotti
Gabriele Bertotti
IEIgnacio Elizagaray-García
Ignacio Elizagaray-García
JRJaime Rodríguez-Vico
Jaime Rodríguez-Vico
AGAlfonso Gil-Martínez
Alfonso Gil-Martínez
Cluster Headache (CH) is a primary headache that causes severe pain. Some evidence suggests that central mechanisms might be involved. The objective of this study was (1) to compare hyperalgesia signs, temporal summation and conditioned pain modulation among episodic (ECH) and chronic CH (CCH) patients and controls, (2) to compare these factors between sides in the patient groups and (3) to compare the psychophysical variables between the groups. This cross-sectional study included 71 subjects divided into three groups (ECH, CCH and controls). Pressure pain thresholds, temporal summation, conditioned pain modulation and other psychosocial variables were measured. The ANOVA showed differences for all physical outcome measures (p < 0.05). Bonferroni post hoc analyses showed differences when comparing the patient groups with the healthy subjects (p < 0.05), with large effect sizes (d > 0.8). No differences between the patient groups were found for almost all the variables (p > 0.05). Significant differences for all the variables were detected when comparing the symptomatic and non-symptomatic sides in both the ECH and CCH groups (p < 0.05). The ECH and CCH groups showed mechanical hyperalgesia, increased temporal summation and impaired inhibitory mechanisms compared to the controls. Side-to-side differences were also detected within the patient groups. Patients with CCH had poorer sleep quality and quality of life than the controls.

16 February 2024 in The Journal of Pain
Verified
Journal Article
Closed access
Gabriele BertottiGabriele Bertotti
Gabriele Bertotti
AGAlfonso Gil-Martínez
Alfonso Gil-Martínez
LMLuis Matesanz-García
Luis Matesanz-García
SASantiago Angulo-Díaz-Parreño
Santiago Angulo-Díaz-Parreño
JRJaime Rodríguez-Vico
Jaime Rodríguez-Vico
JEJuan Ignacio Elizagaray-García
Juan Ignacio Elizagaray-García

25 May 2026 in Nutrition
Verified
Journal Article
Open access
PMPaula Marrero-Fernández
Paula Marrero-Fernández
UFUjué Fresán
Ujué Fresán
SNSiobhan Nicaudie
Siobhan Nicaudie
NHNoelia Rodrigo Huecas
Noelia Rodrigo Huecas
MAMuthanna Abusaada
Muthanna Abusaada
MLMiguel López-Moreno
Miguel López-Moreno
Fibromyalgia (FM) is associated with adverse cardiometabolic profiles and reduced quality of life. Although plant-based dietary patterns have shown cardiovascular benefits, their effects in FM remain unclear. This randomized, parallel-arm controlled trial evaluated the effect of a vegan Mediterranean diet (VegMedDiet) compared with a traditional Mediterranean diet (MedDiet) on low-density lipoprotein cholesterol (LDL-C) and FM-related outcomes. Twenty-two women with FM were assigned to follow either a VegMedDiet (n = 11) or a MedDiet (n = 11) for 6 weeks. Diets were isocaloric and matched for macronutrient distribution. The primary outcome was change in LDL-C; secondary outcomes included other cardiometabolic markers, body composition, and FM-related symptoms and were considered exploratory. Outcomes were analyzed using linear mixed-effects models accounting for repeated measures. Compared with the MedDiet, the VegMedDiet produced greater reductions in LDL-C (estimated mean difference -21.2 mg/dL; 95% CI: -38.3 to -4.08) and triglycerides (-27.4 mg/dL; 95% CI: -52.1 to -2.73). Additionally, a significantly greater reduction was observed in the FIQ pain item (estimated mean difference -1.88; 95% CI: -2.99 to -0.77; P = 0.002). These findings suggest that a VegMedDiet may contribute to short-term improvements in cardiometabolic risk markers and FM-related symptoms compared with a MedDiet, supporting its potential role as a dietary strategy in individuals with FM.